喬翡利亞醫藥有限公司

疾病預防 我們採用25年來專注於5600種菇菌類研究的菌種中心（台灣第一）的原料，為了評估原料功效，我們特別派駐藥學博士針對功效性（藥理活性）、差異性（加乘功效），及人體安全性臨床測試等三項訴求，建立屬於Chphilia公司的預防慢性疾病原料開發系統，以有效管控產品出廠品質。 為了使公司在『疾病預防』的產品項目上做到最好，公司不斷透過期刊、醫師以及學術醫療單位，來評估多種機能性輔助食品效用; 並透過代理與醫師介紹方式，以嚴謹的醫學臨床數據檢視所要代理經營之產品，並確認原廠在理念、訴求與品牌經營方針上的完善性，確實保障我們的醫師及病患售後服務需求。 We collected raw materials from the Fungus Research Center (ranked No. 1 in Taiwan) that has 25 years of research on 5,600 kinds of mushrooms. To evaluate the effect of these raw materials, we assigned a doctor of pharmacy to investigate the efficacy (pharmacological activity) and discrepancy (synergistic effect) of these materials, as well as the safety considerations for clinical testing. The establishment of CHphilia’s raw material development system for the prevention of chronic diseases to effectively control the quality of products produced from the factory. In order to achieve the best disease prevention services, our company continuously evaluates the effect of a variety of functional supplements by gathering information from journals, physicians, and medical institutions. CHphilia reviews and determines the suitability to adopt a product based on the recommendations provided by physicians, distributors, as well as clinical data. We further ensure the intentions of the original manufacturer, whether their intentions satisfy the demands of our customers, as well as the ability for physicians and patients to receive adequate after-sales services when required. 醫療美容 我們於2014年委託台大醫院與台北醫學大學開發可『透過肌膚細胞達到自體修復』並且『加速皮膚細胞生長癒合』兩樣特性的敷料產品。於2017年克服製程放大測試後，同年推出適用於減緩燒燙傷與二期糖尿病傷口癒合需求的『S-CDM1⁺』與『LACTOLAB PRO』產品，臨床上特別適用於皮膚炎、痘痘肌膚、醫療美容創傷和紅腫的受損肌膚修復。 In 2014, we appointed National Taiwan University Hospital and Taipei Medical University to help us develop dressing products. These products can facilitate skin cells to achieve self-repair and accelerate skin cell growth and healing. After overcoming the process amplification test in 2017, in the same year, "S-CDM1⁺" and "LACTOLAB PRO" were successfully launched. They are suitable for alleviating burn wounds and facilitating wound healing in type II diabetes. Clinically, these are particularly suitable for dermatitis, acne, and repair of damaged skin as a result of esthetic procedures. 疾病治療 在德國治療疾病的臨床經驗以及創新溫和方式，令我們驚艷。公司透過代理相關治療儀器，讓病患將不再只有依靠藥物控制的選擇，而是能溫和無負擔的有效控制或是恢復健康。 我們認為革新的醫療技術旨在用溫和有效的治癒方式。為減少痛苦並加快康復速度，治療上盡可能透過物理性的運作系統，促進自身免疫力提升來增強輔助其他治療系統的策略，我們相信這是目前對於患者最有益處的最佳解決方案。 After witnessing the clinical testing conducted in Germany, their use of innovative and non-invasive methods to treat diseases has surprised us. Acting as the distributors for these medical products, patients now have alternative options other than relying on their conventional drugs. This allows them to effectively recover through the means of non-invasive and effective treatment options. We believe that innovative medical treatments should be aimed towards non-invasive and effective treatment methods. To reduce pain and accelerate the recovery process, we aim to use physical methods to promote self-immunity and provide strategies that help assist in other treatments. We believe this is currently the best solution that is most beneficial to patients.